The anticoagulant efficacy of rivaroxaban may be attenuated in cirrhotic patients.

De Gottardi, Andrea; Garcia-Pagan, Juan Carlos (2017). The anticoagulant efficacy of rivaroxaban may be attenuated in cirrhotic patients. Liver international, 37(8), p. 1252. Wiley 10.1111/liv.13420

[img] Text
Gottardi_et_al-2017-Liver_International(1).pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (158kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology

UniBE Contributor:

De Gottardi, Andrea

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1478-3231

Publisher:

Wiley

Language:

English

Submitter:

Thi Thao Anh Pham

Date Deposited:

31 Jan 2018 16:33

Last Modified:

01 Feb 2018 15:01

Publisher DOI:

10.1111/liv.13420

PubMed ID:

28710817

BORIS DOI:

10.7892/boris.109508

URI:

https://boris.unibe.ch/id/eprint/109508

Actions (login required)

Edit item Edit item
Provide Feedback